Cargando…
PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer
BACKGROUND: Protein tyrosine phosphatase non-receptor type 1 (PTPN1), a member of the protein tyrosine phosphatase superfamily, has been identified as an oncogene and therapeutic target in various cancers. However, its precise role in determining the prognosis of human cancer and immunological respo...
Autores principales: | Zhao, Ruijun, Chen, Shuanglong, Cui, Weiheng, Xie, Chaoyu, Zhang, Aiping, Yang, Li, Dong, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626546/ https://www.ncbi.nlm.nih.gov/pubmed/37936713 http://dx.doi.org/10.3389/fimmu.2023.1232047 |
Ejemplares similares
-
Prognostic value and immunological role of PTPN21 in pan-cancer analysis
por: Yang, YanE, et al.
Publicado: (2023) -
PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
por: Dong, Hongmei, et al.
Publicado: (2022) -
NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
por: Wang, Qi, et al.
Publicado: (2023) -
A pan-cancer analysis confirms PTPN11’s potential as a prognostic and immunological biomarker
por: Cao, Yapeng, et al.
Publicado: (2022) -
Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)